The new bedside monitoring system continuously measures heart rate, breath rate and motion without requiring patient contact, according to the release. Constantly monitoring vitals and receiving reports of vital trends can help reduce the potential for an adverse event, according to the release.
More Articles on the FDA:
FDA Clears Smiths Medical to Market Patient-Controlled Pain
FDA Approves Gore Medical’s Viabhan Endoprosthesis Devices Use Expansion
FDA, European Medicines Agency to Collaborate on Generic Drug Approvals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
